Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
3,204
archived clinical trials in
Healthy Studies

Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults
A Phase I, Double-Blind, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults
Status: Enrolling
Updated:  12/31/1969
ICON Early Phase Services
mi
from
San Antonio, TX
Study to Evaluate Safety and PK of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults
A Phase I, Double-Blind, Dose Escalation Study to Evaluate the Safety and Pharmacokinetics of NTM-1634 vs Placebo Administered Intravenously in Healthy Adults
Status: Enrolling
Updated: 12/31/1969
ICON Early Phase Services
mi
from
San Antonio, TX
Click here to add this to my saved trials
A Study to Examine the Effects of Entinostat on Midazolam in Healthy Adult Subjects
An Open Label, 2-Period Study to Assess the Effect of Entinostat on the Pharmacokinetics of Midazolam in Healthy Adult Subjects
Status: Enrolling
Updated:  12/31/1969
Celerion
mi
from
Lincoln, NE
A Study to Examine the Effects of Entinostat on Midazolam in Healthy Adult Subjects
An Open Label, 2-Period Study to Assess the Effect of Entinostat on the Pharmacokinetics of Midazolam in Healthy Adult Subjects
Status: Enrolling
Updated: 12/31/1969
Celerion
mi
from
Lincoln, NE
Click here to add this to my saved trials
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GDC-0853 in Healthy Japanese and Caucasian Participants
A Phase 1, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GDC-0853 in Healthy Japanese and Caucasian Subjects
Status: Enrolling
Updated:  12/31/1969
West Coast Clinical Trials, LLC
mi
from
Cypress, CA
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GDC-0853 in Healthy Japanese and Caucasian Participants
A Phase 1, Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GDC-0853 in Healthy Japanese and Caucasian Subjects
Status: Enrolling
Updated: 12/31/1969
West Coast Clinical Trials, LLC
mi
from
Cypress, CA
Click here to add this to my saved trials
A Study to Assess the Impact of Speed and Site of Subcutaneous Injection on Pain, Tolerability, Safety, and Pharmacokinetics of Gantenerumab in Healthy Participants
A Single-Center, Randomized, Open-Label, Parallel-Group, Placebo-Controlled, Cross-Over Study To Investigate the Impact of Speed of Injection and Site of Injection on Pain, Tolerability, Safety, and Pharmacokinetics Following Subcutaneous Administration of Gantenerumab in Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
PRA International Clinical Pharmacology Center (EDS US Clinic)
mi
from
Lenexa, KA
A Study to Assess the Impact of Speed and Site of Subcutaneous Injection on Pain, Tolerability, Safety, and Pharmacokinetics of Gantenerumab in Healthy Participants
A Single-Center, Randomized, Open-Label, Parallel-Group, Placebo-Controlled, Cross-Over Study To Investigate the Impact of Speed of Injection and Site of Injection on Pain, Tolerability, Safety, and Pharmacokinetics Following Subcutaneous Administration of Gantenerumab in Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
PRA International Clinical Pharmacology Center (EDS US Clinic)
mi
from
Lenexa, KA
Click here to add this to my saved trials
Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory Markers
An Open-label, Pilot Trial to Assess the Effects of a Dietary Supplement on Fasting Lipoprotein Lipids and a Marker of Inflammation in Men and Women With Above-desirable Levels of Low-density Lipoprotein Cholesterol
Status: Enrolling
Updated:  12/31/1969
MB Clinical Research, LLC
mi
from
Boca Raton, FL
Effects of a Dietary Supplement on Lipoprotein Lipids and Inflammatory Markers
An Open-label, Pilot Trial to Assess the Effects of a Dietary Supplement on Fasting Lipoprotein Lipids and a Marker of Inflammation in Men and Women With Above-desirable Levels of Low-density Lipoprotein Cholesterol
Status: Enrolling
Updated: 12/31/1969
MB Clinical Research, LLC
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Evaluation of Changes in Skin Carotenoid Scores in Medical Students Following a Dietary Supplement-based Intervention
Evaluation of Changes in Skin Carotenoid Score in Medical Students Following a Dietary Supplement-based Intervention
Status: Enrolling
Updated:  12/31/1969
Texas Tech University Health Sciences Center
mi
from
Lubbock, TX
Evaluation of Changes in Skin Carotenoid Scores in Medical Students Following a Dietary Supplement-based Intervention
Evaluation of Changes in Skin Carotenoid Score in Medical Students Following a Dietary Supplement-based Intervention
Status: Enrolling
Updated: 12/31/1969
Texas Tech University Health Sciences Center
mi
from
Lubbock, TX
Click here to add this to my saved trials
Well-Being and Physical Activity Study
Well-Being and Physical Activity Study
Status: Enrolling
Updated:  12/31/1969
University of Miami
mi
from
Coral Gables, FL
Well-Being and Physical Activity Study
Well-Being and Physical Activity Study
Status: Enrolling
Updated: 12/31/1969
University of Miami
mi
from
Coral Gables, FL
Click here to add this to my saved trials
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Multiple Doses of TAK-831 in Healthy Participants
A Randomized, Investigator and Subject Blinded, Sponsor Unblinded Placebo-Controlled Phase I Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Multiple Doses of TAK-831 in Healthy Subjects
Status: Enrolling
Updated:  12/31/1969
California Clinical Trials Medical Group/PAREXEL
mi
from
Glendale, CA
A Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Multiple Doses of TAK-831 in Healthy Participants
A Randomized, Investigator and Subject Blinded, Sponsor Unblinded Placebo-Controlled Phase I Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Escalating Multiple Doses of TAK-831 in Healthy Subjects
Status: Enrolling
Updated: 12/31/1969
California Clinical Trials Medical Group/PAREXEL
mi
from
Glendale, CA
Click here to add this to my saved trials
Impact of Increased Parent Presence in the Neonatal Intensive Care Unit on Parent & Infant Outcomes
Impact of Increased Parent Presence in the NICU on Parent & Infant Outcomes
Status: Enrolling
Updated:  12/31/1969
Neonatal Intensive Care Unit, Children's Memorial Hospital
mi
from
Chicago, IL
Impact of Increased Parent Presence in the Neonatal Intensive Care Unit on Parent & Infant Outcomes
Impact of Increased Parent Presence in the NICU on Parent & Infant Outcomes
Status: Enrolling
Updated: 12/31/1969
Neonatal Intensive Care Unit, Children's Memorial Hospital
mi
from
Chicago, IL
Click here to add this to my saved trials
Impact of Increased Parent Presence in the Neonatal Intensive Care Unit on Parent & Infant Outcomes
Impact of Increased Parent Presence in the NICU on Parent & Infant Outcomes
Status: Enrolling
Updated:  12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Impact of Increased Parent Presence in the Neonatal Intensive Care Unit on Parent & Infant Outcomes
Impact of Increased Parent Presence in the NICU on Parent & Infant Outcomes
Status: Enrolling
Updated: 12/31/1969
Ann & Robert H. Lurie Children's Hospital of Chicago
mi
from
Chicago, IL
Click here to add this to my saved trials
Smart Television and Exercise Promotion for Independent Living Facilities
Smart Television and Exercise Promotion for Independent Living Facilities
Status: Enrolling
Updated:  12/31/1969
Klein Buendel, Inc
mi
from
Golden, CO
Smart Television and Exercise Promotion for Independent Living Facilities
Smart Television and Exercise Promotion for Independent Living Facilities
Status: Enrolling
Updated: 12/31/1969
Klein Buendel, Inc
mi
from
Golden, CO
Click here to add this to my saved trials
Participation of Breast Milk Feeding Mothers in Research
Participation of Breast Milk Feeding Mothers in Research
Status: Enrolling
Updated:  12/31/1969
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Participation of Breast Milk Feeding Mothers in Research
Participation of Breast Milk Feeding Mothers in Research
Status: Enrolling
Updated: 12/31/1969
Pennington Biomedical Research Center
mi
from
Baton Rouge, LA
Click here to add this to my saved trials
A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the Body
Single-center, Double-blind, Placebo-controlled, Randomized, Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of AC-076 in Healthy Male Subjects
Status: Enrolling
Updated:  12/31/1969
Biotrial Inc.
mi
from
Newark, NJ
A Study Conducted in Healthy Male Subjects to Investigate the Safety and Tolerability of AC-76, Its Fate in the Body, and Its Effect on the Body
Single-center, Double-blind, Placebo-controlled, Randomized, Single-ascending Dose Study to Investigate the Tolerability, Safety, Pharmacokinetics, and Pharmacodynamics of AC-076 in Healthy Male Subjects
Status: Enrolling
Updated: 12/31/1969
Biotrial Inc.
mi
from
Newark, NJ
Click here to add this to my saved trials
Investigation of Exercise Training-Induced Myokines and Adipolkines in Humans
Investigation of Exercise Training-Induced Myokines and Adipolkines in Humans
Status: Enrolling
Updated:  12/31/1969
Joslin Diabetes Center
mi
from
Boston, MA
Investigation of Exercise Training-Induced Myokines and Adipolkines in Humans
Investigation of Exercise Training-Induced Myokines and Adipolkines in Humans
Status: Enrolling
Updated: 12/31/1969
Joslin Diabetes Center
mi
from
Boston, MA
Click here to add this to my saved trials
In Vivo Recovery and Survival Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution
An In Vivo Recovery and Survival Study of Platelets Collected on the Trima Accel System and Stored in InterSol Solution
Status: Enrolling
Updated:  12/31/1969
Hoxworth Blood Center
mi
from
Cincinnati, OH
In Vivo Recovery and Survival Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution
An In Vivo Recovery and Survival Study of Platelets Collected on the Trima Accel System and Stored in InterSol Solution
Status: Enrolling
Updated: 12/31/1969
Hoxworth Blood Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
In Vivo Recovery and Survival Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution
An In Vivo Recovery and Survival Study of Platelets Collected on the Trima Accel System and Stored in InterSol Solution
Status: Enrolling
Updated:  12/31/1969
BloodCenter of Wisconsin
mi
from
Milwaukee, WI
In Vivo Recovery and Survival Study of Platelets Collected on Trima Accel System and Stored in InterSol Solution
An In Vivo Recovery and Survival Study of Platelets Collected on the Trima Accel System and Stored in InterSol Solution
Status: Enrolling
Updated: 12/31/1969
BloodCenter of Wisconsin
mi
from
Milwaukee, WI
Click here to add this to my saved trials
Probiotics Effect on the Female Urinary Microbiome ProFUM Trial (Probiotics Effect on the Female Urinary Microbiome)
Probiotics and the Female Urinary Microbiome ProFUM Trial (Probiotics Effect on the Female Urinary Microbiome)
Status: Enrolling
Updated:  12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
Probiotics Effect on the Female Urinary Microbiome ProFUM Trial (Probiotics Effect on the Female Urinary Microbiome)
Probiotics and the Female Urinary Microbiome ProFUM Trial (Probiotics Effect on the Female Urinary Microbiome)
Status: Enrolling
Updated: 12/31/1969
Loyola University Medical Center
mi
from
Maywood, IL
Click here to add this to my saved trials
Health Benefits of Gardening
Assessing Human Health Benefits of Gardening
Status: Enrolling
Updated:  12/31/1969
Fifield and Merhof Halls
mi
from
Gainesville, FL
Health Benefits of Gardening
Assessing Human Health Benefits of Gardening
Status: Enrolling
Updated: 12/31/1969
Fifield and Merhof Halls
mi
from
Gainesville, FL
Click here to add this to my saved trials
Health Benefits of Gardening
Assessing Human Health Benefits of Gardening
Status: Enrolling
Updated:  12/31/1969
Wilmot Gardens Conference Center and Greenhouse
mi
from
Gainesville, FL
Health Benefits of Gardening
Assessing Human Health Benefits of Gardening
Status: Enrolling
Updated: 12/31/1969
Wilmot Gardens Conference Center and Greenhouse
mi
from
Gainesville, FL
Click here to add this to my saved trials
Computational Drug Repurposing for EBS
Computational Drug Repurposing for Epidermolysis Bullosa Simplex
Status: Enrolling
Updated:  12/31/1969
Pediatric Dermatology Clinic at Stanford Children's Hospital
mi
from
Palo Alto, CA
Computational Drug Repurposing for EBS
Computational Drug Repurposing for Epidermolysis Bullosa Simplex
Status: Enrolling
Updated: 12/31/1969
Pediatric Dermatology Clinic at Stanford Children's Hospital
mi
from
Palo Alto, CA
Click here to add this to my saved trials
2-HOBA: Initial Evaluation in Humans
2-Hydroxybenzylamine: Initial Evaluation in Humans
Status: Enrolling
Updated:  12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
2-HOBA: Initial Evaluation in Humans
2-Hydroxybenzylamine: Initial Evaluation in Humans
Status: Enrolling
Updated: 12/31/1969
Vanderbilt University Medical Center
mi
from
Nashville, TN
Click here to add this to my saved trials
The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity
The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity
Status: Enrolling
Updated:  12/31/1969
Texas Diabetic Institute
mi
from
San Antonio, TX
The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity
The Physiologic Effects of Intranasal Oxytocin on Sarcopenic Obesity
Status: Enrolling
Updated: 12/31/1969
Texas Diabetic Institute
mi
from
San Antonio, TX
Click here to add this to my saved trials
The Effects of Ginger Supplementation on Inflammation in Exercising Individuals
The Effects of Ginger Supplementation on Inflammation in Exercising Individuals
Status: Enrolling
Updated:  12/31/1969
Loma Linda Health
mi
from
Loma Linda, CA
The Effects of Ginger Supplementation on Inflammation in Exercising Individuals
The Effects of Ginger Supplementation on Inflammation in Exercising Individuals
Status: Enrolling
Updated: 12/31/1969
Loma Linda Health
mi
from
Loma Linda, CA
Click here to add this to my saved trials
WILD 5 Wellness: A 90-Day Intervention (WILD = Wellness Interventions for Life's Demands)
WILD 5 Wellness: A 90-Day Intervention (WILD = Wellness Interventions for Life's Demands)
Status: Enrolling
Updated:  12/31/1969
University of Texas at Austin School of Nursing
mi
from
Austin, TX
WILD 5 Wellness: A 90-Day Intervention (WILD = Wellness Interventions for Life's Demands)
WILD 5 Wellness: A 90-Day Intervention (WILD = Wellness Interventions for Life's Demands)
Status: Enrolling
Updated: 12/31/1969
University of Texas at Austin School of Nursing
mi
from
Austin, TX
Click here to add this to my saved trials
Probiotics on Stress-associated Gastrointestinal Function in University Students
Probiotics (Lactobacillus Gasseri KS-13, Bifidobacterium Bifidum G9-1, Bifidobacterium Longum MM-2) on Stress-associated Gastrointestinal Function in University Students: a Randomized, Double-blind, Placebo-controlled Clinical Trial
Status: Enrolling
Updated:  12/31/1969
University of Florida
mi
from
Gainesville, FL
Probiotics on Stress-associated Gastrointestinal Function in University Students
Probiotics (Lactobacillus Gasseri KS-13, Bifidobacterium Bifidum G9-1, Bifidobacterium Longum MM-2) on Stress-associated Gastrointestinal Function in University Students: a Randomized, Double-blind, Placebo-controlled Clinical Trial
Status: Enrolling
Updated: 12/31/1969
University of Florida
mi
from
Gainesville, FL
Click here to add this to my saved trials
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Savannah, GA
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Savannah, GA
Click here to add this to my saved trials
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Bardstown, KY
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Bardstown, KY
Click here to add this to my saved trials
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Norfolk, NE
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Norfolk, NE
Click here to add this to my saved trials
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Omaha, NE
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Omaha, NE
Click here to add this to my saved trials
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Binghamton, NY
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Binghamton, NY
Click here to add this to my saved trials
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Dakota Dunes, SD
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Dakota Dunes, SD
Click here to add this to my saved trials
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Fort Worth, TX
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
San Angelo, TX
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
San Angelo, TX
Click here to add this to my saved trials
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Tomball, TX
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Tomball, TX
Click here to add this to my saved trials
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
West Jordan, UT
Evaluate the Shedding and Immunogencity of Different Formulations of FluMist in Children 24 to <48 Months of Age
A Phase 4 Double-blind Study to Evaluate the Shedding and Immunogenicity of Trivalent and Quadrivalent Formulations of FluMist in Children 24 to < 48 Months of Age
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
West Jordan, UT
Click here to add this to my saved trials
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis
A Prospective, Controlled, Double Blind, Multi-Center, Randomized, 3 Arm, Phase 1b/2a Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 Delivered as an Intranasal Spray in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  12/31/1969
Orange County Research Center
mi
from
Tustin, CA
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis
A Prospective, Controlled, Double Blind, Multi-Center, Randomized, 3 Arm, Phase 1b/2a Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 Delivered as an Intranasal Spray in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 12/31/1969
Orange County Research Center
mi
from
Tustin, CA
Click here to add this to my saved trials
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis
A Prospective, Controlled, Double Blind, Multi-Center, Randomized, 3 Arm, Phase 1b/2a Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 Delivered as an Intranasal Spray in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated:  12/31/1969
Inflamax
mi
from
Mississauga,
Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis
A Prospective, Controlled, Double Blind, Multi-Center, Randomized, 3 Arm, Phase 1b/2a Study to Assess the Safety, Tolerability, and Preliminary Efficacy of B244 Delivered as an Intranasal Spray in Healthy Volunteers and Subjects With Seasonal Allergic Rhinitis
Status: Enrolling
Updated: 12/31/1969
Inflamax
mi
from
Mississauga,
Click here to add this to my saved trials
Collagen Vitamin C Dose Response Performance
Effects of Hydrolyzed Collagen and Vitamin C on Collagen Synthesis and Explosive Performance
Status: Enrolling
Updated:  12/31/1969
University of California Davis
mi
from
Davis, CA
Collagen Vitamin C Dose Response Performance
Effects of Hydrolyzed Collagen and Vitamin C on Collagen Synthesis and Explosive Performance
Status: Enrolling
Updated: 12/31/1969
University of California Davis
mi
from
Davis, CA
Click here to add this to my saved trials
Cognitive, Emotional, and Neural Responses to Acute Inflammation
Cognitive, Emotional, and Neural Responses to Acute Inflammation
Status: Enrolling
Updated:  12/31/1969
San Francisco Veterans Affairs Medical Center
mi
from
San Francisco, CA
Cognitive, Emotional, and Neural Responses to Acute Inflammation
Cognitive, Emotional, and Neural Responses to Acute Inflammation
Status: Enrolling
Updated: 12/31/1969
San Francisco Veterans Affairs Medical Center
mi
from
San Francisco, CA
Click here to add this to my saved trials
Cognitive, Emotional, and Neural Responses to Acute Inflammation
Cognitive, Emotional, and Neural Responses to Acute Inflammation
Status: Enrolling
Updated:  12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Cognitive, Emotional, and Neural Responses to Acute Inflammation
Cognitive, Emotional, and Neural Responses to Acute Inflammation
Status: Enrolling
Updated: 12/31/1969
University of California at San Francisco
mi
from
San Francisco, CA
Click here to add this to my saved trials
Expanding Rural Access to Breastfeeding Support Via Telehealth: The Tele-MILC Trial
Status: Enrolling
Updated:  12/31/1969
RAND Corporation
mi
from
Arlington, VA
Expanding Rural Access to Breastfeeding Support Via Telehealth: The Tele-MILC Trial
Status: Enrolling
Updated: 12/31/1969
RAND Corporation
mi
from
Arlington, VA
Click here to add this to my saved trials
The Effects of Dark Chocolate (70% Cacao) on EEG Brain Waves in Vigorously Active Individuals
The Effects of Dark Chocolate (70% Cacao) on EEG Brain Waves in Vigorously Active Individuals
Status: Enrolling
Updated:  12/31/1969
Loma Linda U
mi
from
Loma Linda, CA
The Effects of Dark Chocolate (70% Cacao) on EEG Brain Waves in Vigorously Active Individuals
The Effects of Dark Chocolate (70% Cacao) on EEG Brain Waves in Vigorously Active Individuals
Status: Enrolling
Updated: 12/31/1969
Loma Linda U
mi
from
Loma Linda, CA
Click here to add this to my saved trials
A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers
Phase 1, Randomized Open Label, Multiple Dose, Parallel Study To Assess The Immunogenicity Of Multiple Subcutaneous (SC) Doses Of The Proposed Pegfilgrastim Biosimilar (PF-06881894) And Us-approved Neulasta (Registered) In Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
Seaview A Quotient Clinical Business
mi
from
Coral Gables, FL
A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers
Phase 1, Randomized Open Label, Multiple Dose, Parallel Study To Assess The Immunogenicity Of Multiple Subcutaneous (SC) Doses Of The Proposed Pegfilgrastim Biosimilar (PF-06881894) And Us-approved Neulasta (Registered) In Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Seaview A Quotient Clinical Business
mi
from
Coral Gables, FL
Click here to add this to my saved trials
A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers
Phase 1, Randomized Open Label, Multiple Dose, Parallel Study To Assess The Immunogenicity Of Multiple Subcutaneous (SC) Doses Of The Proposed Pegfilgrastim Biosimilar (PF-06881894) And Us-approved Neulasta (Registered) In Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
Seaview A Quotient Clinical Business
mi
from
Miami, FL
A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers
Phase 1, Randomized Open Label, Multiple Dose, Parallel Study To Assess The Immunogenicity Of Multiple Subcutaneous (SC) Doses Of The Proposed Pegfilgrastim Biosimilar (PF-06881894) And Us-approved Neulasta (Registered) In Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Seaview A Quotient Clinical Business
mi
from
Miami, FL
Click here to add this to my saved trials
A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers
Phase 1, Randomized Open Label, Multiple Dose, Parallel Study To Assess The Immunogenicity Of Multiple Subcutaneous (SC) Doses Of The Proposed Pegfilgrastim Biosimilar (PF-06881894) And Us-approved Neulasta (Registered) In Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
Vince and Associates Clinical Research
mi
from
Overland Park, KA
A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers
Phase 1, Randomized Open Label, Multiple Dose, Parallel Study To Assess The Immunogenicity Of Multiple Subcutaneous (SC) Doses Of The Proposed Pegfilgrastim Biosimilar (PF-06881894) And Us-approved Neulasta (Registered) In Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Vince and Associates Clinical Research
mi
from
Overland Park, KA
Click here to add this to my saved trials
A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers
Phase 1, Randomized Open Label, Multiple Dose, Parallel Study To Assess The Immunogenicity Of Multiple Subcutaneous (SC) Doses Of The Proposed Pegfilgrastim Biosimilar (PF-06881894) And Us-approved Neulasta (Registered) In Healthy Volunteers
Status: Enrolling
Updated:  12/31/1969
Quotient Sciences- Jacksonville, LLC
mi
from
Jacksonville, FL
A Study to Assess Immune Response to Multiple Doses of PF-06881894 or US-Approved Neulasta in Healthy Volunteers
Phase 1, Randomized Open Label, Multiple Dose, Parallel Study To Assess The Immunogenicity Of Multiple Subcutaneous (SC) Doses Of The Proposed Pegfilgrastim Biosimilar (PF-06881894) And Us-approved Neulasta (Registered) In Healthy Volunteers
Status: Enrolling
Updated: 12/31/1969
Quotient Sciences- Jacksonville, LLC
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Pilot Comparison of N-of-1 Trials of Light Therapy
Comparison of N-of-1 Trials of Light Therapy for Depressive Symptoms in Cancer Survivors
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Pilot Comparison of N-of-1 Trials of Light Therapy
Comparison of N-of-1 Trials of Light Therapy for Depressive Symptoms in Cancer Survivors
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center
mi
from
New York, NY
Click here to add this to my saved trials
Genetic and Environmental Factors in the Response to Influenza Vaccination
Genetic and Environmental Factors in the Response to Influenza Vaccination
Status: Enrolling
Updated:  12/31/1969
Stanford University
mi
from
Stanford, CA
Genetic and Environmental Factors in the Response to Influenza Vaccination
Genetic and Environmental Factors in the Response to Influenza Vaccination
Status: Enrolling
Updated: 12/31/1969
Stanford University
mi
from
Stanford, CA
Click here to add this to my saved trials